Navigation Links
VirtualScopics Announces $4.35 Million Private Placement
Date:9/17/2007

ons. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Many of these risks and uncertainties are discussed in the Company's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006 filed with the Securities and Exchange Commission (the "SEC"), and in any subsequent reports filed with the SEC, all of which are available at the SEC's website at http://www.sec.gov. These include without limitation: risks related to the dependence on our largest customers until we can further diversify our customer base; risks of contract performance; and risks of contract termination. All forward-looking statements speak only as of the date of this press release and the Company undertakes no obligation to update such forward-looking statements.

CONTACT:

Tracy Bagatelle-Black

Bagatelle-Black Public Relations

661/263-1842

tracy@bagatelleblack.com

Tim Ryan

Trout Group Investor Relations

646/378-2924

tryan@troutgroup.com


'/>"/>
SOURCE VirtualScopics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...lastic surgeons to be greedier! Not satisfied with...nt on a French woman, plastic surgeons are hungry ...rting in the March issue of Plastic and Reconstruc... of the American Society of Plastic Surgeons (ASPS...
...hers at the Injury Research Center of the Medical ...ith the highest body mass index (BMI) and those wi...om crashes. // Obesity and being slim increases ... car crash. On the other hand being moderately ov...
...torial mess at the Canadian Medical Association jo...ditor Stephen Choi and editorial fellow Sally Murr...l in resigning from their posts after a dispute ov... Plan B. Dr. Bruce Squires has been asked to act...
...eakthrough research scientists in Victoria have cl...wo deadly animal viruses.// These two viruses in ...lly be used by terrorists. The charge sheet agains...rus emerged in 1994, killing prominent Queensland ...
Other Medicine News:
(Date:10/6/2008)...nt of moderate to severe patients achieved endosco...oscopic remission at Week 10,in data from a 54-wee...ge,of Gastroenterology (ACG) Annual Scientific Mee...oday presented data from a,large, prospective stud...disease (CD) with a biologic compound. The data pr...
(Date:10/6/2008)...ther Product - Company,s Bioabsorbable Stent - Als..., Oct. 6 /- Data from multiple clinic...OrbusNeich,s Genous Bio-engineered R,stent, will b...ascular,Therapeutics symposium, TCT 2008, in Washi...he Academic Medical Center in,Amsterdam will provi...
(Date:10/3/2008)..., Oct. 3 /- deCODE genetics... investigational new drug,(IND) application for DG...of phosphodiesterase 4 (PDE4), with the US Food an... developed as a new and potentially safer means,of...e deficits associated,with Alzheimer,s disease and...
(Date:10/2/2008)...- Pharmaleads has obtained from the,F...to perform a single,ascending dose Phase I study w...neuropathic pain., Neuropathic pain is a major ch... in the world,s population of up to 6%, according ...as shingles, herpes, diabetes,antiviral or antitu...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2New method developed to identify genetic determinants of Alzheimers disease 1878 1New method developed to identify genetic determinants of Alzheimers disease 1878 2Stem Cells Modified to Home in Where Theyre Needed 9499 1Stem Cells Modified to Home in Where Theyre Needed 9499 2U S Food Safety 3A Home Grown Problems Abound 9497 1U S Food Safety 3A Home Grown Problems Abound 9497 2U S Food Safety 3A Home Grown Problems Abound 9497 3U S Food Safety 3A Home Grown Problems Abound 9497 4U S Food Safety 3A Home Grown Problems Abound 9497 5U S Food Safety 3A Home Grown Problems Abound 9497 6University of Detroit Mercy School of Dentistry Moves to Larger Facility on New Corktown Campus 9495 1University of Detroit Mercy School of Dentistry Moves to Larger Facility on New Corktown Campus 9495 2University of Detroit Mercy School of Dentistry Moves to Larger Facility on New Corktown Campus 9495 3
...omeostasis Effects in,Normal and Diabetic Rats --,...In a 14-day,Phase IIa study of the safety profile... dapagliflozin, a selective inhibitor of,the Sodiu... or,concomitantly with metformin in subjects with ...e events and no serious adverse,events were report...
...Is Commonly Seen In,Insulin Therapy , CHICAGO, Jun...sults of a new study that further demonstrated the...lin detemir [rDNA origin],injection). Patients wi...osage of Levemir® and achieve improvements in ...r primary care,physician. This improvement in A1c...
Other Medicine Technology:First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5
...ALPHA 10 System offers unparalleled image quality ...gonomically designed console., ,The ALPHA 10 i...al Medicine Specialists, large OB/GYN offices, Sur...aging departments in need of exceptional diagnosti...
...ly designed to fit the needs of a single facility ...From test initiation and processing to management ...a facilitates quick, efficient and precise laborat...rated and reside under a single database. Other fe...
CELL-DYN Sapphire, our flagship solution for high-volume laboratories, utilizes patented MAPSS plus 3-color fluorescent technology for improved lab efficiency.
Human growth hormone (hGH, somatotropin) is a polypeptide secreted by the anterior pituitary. It is 191 amino acids in length and has a molecular mass of approximately 22,000 daltons. Its metabolic
Medicine Products: